e-learning
resources
Madrid 2019
Saturday, 28.09.2019
PG2 Thoracic ultrasound
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Assessment of parenchymal abnormalities
C. Laursen (Odense, Denmark)
Source:
International Congress 2019 – PG2 Thoracic ultrasound
Session:
PG2 Thoracic ultrasound
Session type:
Postgraduate Course
Number:
20
Disease area:
-
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Laursen (Odense, Denmark). Assessment of parenchymal abnormalities. International Congress 2019 – PG2 Thoracic ultrasound
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Khalid Hassan Ba-Msahell - 12.03.2020 11:24
Nice Lecture
Khalid Hassan Ba-Msahell - 12.03.2020 11:22
Nice lecture
You must
Login
to comment this presentation.
Related content which might interest you:
Lung ultrasound
Pleural ultrasound
Group assignment
Related content which might interest you:
PET-CT with
18
F-FDG and
18
F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Lung
18
F-FDG uptake correlates with lung function alteration in patients with IPF
Source: International Congress 2014 – ILDs: pathogenesis and clinical features
Year: 2014
Associations of interstitial lung abnormalities with physical function measures
Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias
Year: 2018
Interstitial lung abnormalities and physical function
Source: ERJ Open Res, 4 (3) 00057-2018; 10.1183/23120541.00057-2018
Year: 2018
From HRCT to morphology in diffuse parenchymal lung diseases(DPLDs)
Source: International Congress 2014 – ILDs 1
Year: 2014
Evaluation and correlations of the extension of pulmonary cysts in lymphangioleiomyomatosis
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Comparison of physiological impairment in ILD patients with and without diagnostic IPF features
Source: International Congress 2014 – ILDs 4
Year: 2014
Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients
Source: International Congress 2014 – ILDs 2
Year: 2014
Assessment of disease severity using imaging scores in pulmonary sarcoidosis
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO
Source: International Congress 2014 – ILDs 6
Year: 2014
Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome
Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations
Year: 2014
Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – ILDs 2
Year: 2014
Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis
Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis
Year: 2014
6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations
Source: International Congress 2014 – ILDs 6
Year: 2014
Congenital lung abnormalities
Source: Eur Respir Mon; 2010: 47: 263–276
Year: 2010
Diagnostic defects in interstitial lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 98s
Year: 2006
Oxygen-enhanced MR (OE-MR): Correlation to CT Brody score in cystic fibrosis patients
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016
Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases
Source: International Congress 2014 – ILDs 4
Year: 2014
Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study
Source: International Congress 2014 – COPD and PAH related imaging
Year: 2014
Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry
Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept